2nd CNS Clinical Trials Forum – 2nd CNS Clinical Trials Forum
Pharmaceutical companies developing new CNS products face complex obstacles in improving trial processes and quality in order to optimize products’ life cycles — not only are CNS trials more expensive and more time-consuming than other trials, they’re also less likely to be successful and gain approval. With therapies for CNS-related disorders representing 21% of the total pharmaceutical marketplace but only 8% of CNS drugs making it through clinical trials, it’s clear that a well-executed CNS clinical trial can be extremely lucrative for a company.
To help guide you in your CNS clinical trials, ExL Events is proud to bring you the 2nd CNS Clinical Trials Forum. Join us and discover how to best position your clinical trial for success via unique partnering and licensing agreements, ideal patient recruitment strategies, accurate predictive outcome models, and more.
Top Five Reasons to Attend
Learn how to develop a strong clinical operations team with internal stakeholders and external partners to prepare for successful neuroscience clinical trials
Identify new trends and technologies in CNS product development
Improve endpoint selection and determine how to best compare entry scores and endpoints
Partner with IRBs, sites and other key stakeholders to improve your chances of a successful CNS trial
Lower the risk of the placebo effect in CNS trials
Who Should Attend
This conference is designed for professionals from the pharmaceutical and biotechnology industries, as well as clinical research organizations, with responsibilities in the following areas: